The diagnostics company will open a lab with Corewell Health in 2027 and manage the not-for-profit health system’s existing ...

Corewell Health and Quest Diagnostics have agreed to a joint lab that they say will expand access to affordable services in ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation for Quest Diagnostics’ Haystack minimal ...

Analysts have set 12-month price targets for Quest Diagnostics, revealing an average target of $183.8, a high estimate of ...

Corewell Health and Quest Diagnostics have formed a joint venture to expand laboratory services across Michigan. The new entity, Diagnostic Lab of Michigan, LLC, will operate from a planned ...

Quest Diagnostics Inc. DGX is investing in advanced diagnostics to deliver and scale innovative services that improve patient care and drive growth. Acquisitions remain a key growth driver for the ...

Diagnostic testing and information services provider Quest Diagnostics (NYSE:DGX) reported fiscal 2025 second-quarter results on Tuesday, July 22, that topped analysts' consensus expectations. Q2 ...

Quest predicts 80% drop in 2023 COVID-19 test revenues By Andrea Park Feb 6, 2023 10:33am Quest Diagnostics Earnings COVID-19 diagnostic tests ...

Quest Diagnostics DGX talked about its strategic priorities and growth drivers at the 2023 Investor Day. The company also discussed its shareholder value creation and updated its long-term ...

With this acquisition, Quest will be positioned to provide dialysis-related clinical testing to independent dialysis clinics previously served by Spectra Laboratories.